Clinical Trials Directory

Trials / Completed

CompletedNCT04770909

Log2Lose: Incenting Weight Loss and Dietary Self-monitoring in Real-time to Improve Weight Management Among Adults With Obesity

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
706 (actual)
Sponsor
University of Wisconsin, Madison · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study involves an evaluation of whether providing small incentives weekly for dietary self-monitoring and/or weight loss improves short- and long-term weight loss. Participants can expect to be on study for 18 months.

Detailed description

In this two-site, randomized, single-masked, longitudinal 2x2 factorial study, called Log2Lose, adults with obesity from Madison, WI and Durham, NC will be offered a 78 week, evidence-based behavioral weight management program comprising an incentivized weight loss intervention for 26 weeks (Phase I), an incentivized weight loss maintenance intervention for 26 weeks (Phase II), and a non-incentivized weight maintenance intervention for 26 weeks (Phase III). Participants will be randomized in a 2x2 design to receive adjunctive incentives for either weekly weight loss or dietary self-monitoring, both, or neither. The investigators will assess the proportion of participants achieving clinically significant weight loss of greater than or equal to 5 percent at the end of each phase. All participants will participate in an 18-month weight management program delivered via videoconference.

Conditions

Interventions

TypeNameDescription
BEHAVIORALIncentives for dietary self-monitoring and weight lossParticipants can earn up to $300 during the trial for achieving adequate dietary self-monitoring and weight loss
BEHAVIORALIncentives for dietary self-monitoringParticipants can earn up to $300 during the trial for achieving adequate dietary self-monitoring
BEHAVIORALIncentives for weight lossParticipants can earn up to $300 during the trial for achieving weight loss

Timeline

Start date
2021-05-13
Primary completion
2024-04-08
Completion
2025-04-10
First posted
2021-02-25
Last updated
2025-05-04

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04770909. Inclusion in this directory is not an endorsement.